郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

期刊：PPAR research发表年份：2010作者：Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
阅读更多 →

药效评价Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.

期刊：Journal of medicinal chemistry发表年份：2010作者：Colin P Leslie; Matteo Biagetti; Silvia Bison; Steven M Bromidge; Romano Di Fabio; Daniele Donati; Alessandro Falchi; Martine J Garnier; Albert Jaxa-Chamiec; Gary Manchee; Giancarlo Merlo; Domenica A Pizzi; Luigi P Stasi; Jessica Tibasco; Antonio Von
阅读更多 →

药效评价Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.

期刊：Neuropharmacology发表年份：2010作者：Robert H Ring; Lee E Schechter; Sarah K Leonard; Jason M Dwyer; Brian J Platt; Radka Graf; Steven Grauer; Claudine Pulicicchio; Lynn Resnick; Zia Rahman; Stacey J Sukoff Rizzo; Bin Luo; Chad E Beyer; Sheree F Logue; Karen L Marquis; Zoë A Hughes; Sha
阅读更多 →

药效评价WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2010作者：Julie A Brennan; Radka Graf; Steven M Grauer; Rachel L Navarra; Claudine M Pulicicchio; Zoë A Hughes; Qian Lin; Caitlin Wantuch; Sharon Rosenzweig-Lipson; Farhana Pruthi; Margaret Lai; Deborah Smith; Wouter Goutier; Martina van de Neut; Albert J Robi
阅读更多 →